Australian researchers says they have obtained ‘breakthrough’ results showing a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients. Melanoma Institute Australia Co-Medical Director, Professor Georgina Long will be presenting results of the RELATIVITY-047 trial of relatlimab in melanoma at the American Society of Clinical Oncology virtual meeting this week. ...
Australian research adds third immune checkpoint inhibitor to the melanoma treatment toolkit
By Michael Woodhead
4 Jun 2021